Hancock Whitney Corp Astrazeneca PLC Transaction History
Hancock Whitney Corp
- $5.37 Billion
- Q3 2025
A detailed history of Hancock Whitney Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Hancock Whitney Corp holds 17,195 shares of AZN stock, worth $1.54 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
17,195
Previous 16,896
1.77%
Holding current value
$1.54 Million
Previous $1.18 Million
11.78%
% of portfolio
0.02%
Previous 0.02%
Shares
21 transactions
Others Institutions Holding AZN
# of Institutions
1,528Shares Held
502MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...